Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Lilly Oncology on Canvas Art Exhibit on display in the N.C. Cancer Hospital Lobby November 7-21, 2012
UNC Lineberger Comprehensive Cancer Center is hosting the Lilly Oncology on Canvas Exhibition in the lobby of the N.C. Cancer Hospital.
Located in News / 2012 News
Grant to fund use of kinase test in HER2-positive breast cancer
Chapel Hill, NC – Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.
Located in News / 2012 News
Science, surgery, and start-ups - in depth with Dr. Nancy DeMore
UNC surgeon-scientist Dr. Nancy DeMore says, “As a physician, I’m acutely aware of how much more we need to learn about breast cancer and how urgently we need better therapies. It really gives me hope to be in the lab and to know that I’m working towards something that may make things better for patients.”
Located in News / 2012 News
University Cancer Research Fund panel sets priorities, adds national experts
CHAPEL HILL – The governance committee of the University Cancer Research Fund has established first-year spending priorities for the state’s initial $25 million investment at the University of North Carolina at Chapel Hill.
Located in News / 2011 News
UNC spin-off receives $3M Small Business Innovation Research grant
Chapel Hill, NC – G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Located in News / 2011 News
UNC scientists recommend rethinking brain MRI for early-stage lung cancer patients
UNC scientists report that in early stage, asymptomatic non-small cell lung cancer, early brain recurrences are potentially detectable prior to surgery and recommend that physicians consider including a routine pre-operative staging brain MRI. In addition, patients whose tumors are determined to be higher risk based on the findings at surgery, should consider post-operative MRI to offer early treatment of unrecognized metastasis.
Located in News / 2011 News
UNC, NC community colleges partner to prevent cancer
Project will assess needs and work to accelerate adoption of evidence-based cancer prevention interventions
Located in News / 2011 News
Testicular cancer treatment, one patient's story
UNC Lineberger patient David Alston talks about the treatment he is undergoing for testicular cancer.
Located in News / 2012 News
Charles Perou, PhD, appointed May Goldman Shaw Distinguished Professorship of Molecular Oncology Research
Chapel Hill, NC – Charles M. Perou, PhD, professor of genetics, and pathology & laboratory medicine, and leader of the UNC Lineberger Comprehensive Cancer Center breast cancer research program has been appointed the May Goldman Shaw Distinguished Professor of Molecular Oncology Research. The professorship, established by a $1 million gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas is named in honor of Mrs. Lowenbaum’s mother, May Goldman Shaw.
Located in News / 2011 News
UNC Lineberger scientists lead cancer genome analysis of breast cancer
Team identifies genetic causes and similarity to ovarian cancer
Located in News / 2012 News